AKEEM ADENIYI: Open Payments
NPI 1720513443 · ADA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 116 payments from 12 companies in 2025. Trend: 2023 $1,048 · 2024 $867 · 2025 $1,953
Food & beverage: $1,842Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $589 |
| Otsuka America Pharmaceutical, Inc. | 12 | $321 |
| E.R. Squibb & Sons, L.L.C. | 11 | $225 |
| Braeburn Inc. | 14 | $192 |
| Teva Pharmaceuticals USA, Inc. | 7 | $190 |
| Neurocrine BioSciences, Inc. | 2 | $122 |
| Janssen Pharmaceuticals, Inc | 5 | $87 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Alkermes, Inc. | 2 | $44 |
Products named: VRAYLAR, REXULTI, COBENFY, BRIXADI, INGREZZA, ABILIFY MAINTENA, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
